Show simple item record

dc.contributor.authorFerreiro Fernández, Lucía 
dc.contributor.authorSuárez Antelo, Juan 
dc.contributor.authorAlvarez Dobaño, Jose Manuel 
dc.contributor.authorToubes Navarro, Maria Elena 
dc.contributor.authorRIVEIRO BLANCO, VANESSA 
dc.contributor.authorValdés Cuadrado, Luis 
dc.date.accessioned2022-04-12T11:38:38Z
dc.date.available2022-04-12T11:38:38Z
dc.date.issued2020
dc.identifier.issn1198-2241
dc.identifier.otherhttps://www.ncbi.nlm.nih.gov/pubmed/33273991es
dc.identifier.urihttp://hdl.handle.net/20.500.11940/16475
dc.description.abstractSymptomatic malignant pleural effusion is a common clinical problem. This condition is associated with very high mortality, with life expectancy ranging from 3 to 12 months. Studies are contributing evidence on an increasing number of therapeutic options (therapeutic thoracentesis, thoracoscopic pleurodesis or thoracic drainage, indwelling pleural catheter, surgery, or a combination of these therapies). Despite the availability of therapies, the management of malignant pleural effusion is challenging and is mainly focused on the relief of symptoms. The therapy to be administered needs to be designed on a case-by-case basis considering patient's preferences, life expectancy, tumour type, presence of a trapped lung, resources available, and experience of the treating team. At present, the management of malignant pleural effusion has evolved towards less invasive approaches based on ambulatory care. This approach spares the patient the discomfort caused by more invasive interventions and reduces the economic burden of the disease. A review was performed of the diagnosis and the different approaches to the management of malignant pleural effusion, with special emphasis on their indications, usefulness, cost-effectiveness, and complications. Further research is needed to shed light on the current matters of controversy and help establish a standardized, more effective management of this clinical problem.en
dc.rightsAtribución 4.0 Internacional
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/
dc.subject.meshHumans *
dc.subject.meshDrainage *
dc.subject.meshCatheters *
dc.titleMalignant Pleural Effusion: Diagnosis and Managementen
dc.typeJournal Articlees
dc.authorsophosFerreiro, L.;Suárez-Antelo, J.;Álvarez-Dobaño, J. M.;Toubes, M. E.;Riveiro, V.;Valdés, L.
dc.identifier.doi10.1155/2020/2950751
dc.identifier.pmid33273991
dc.identifier.sophos39036
dc.issue.number1es
dc.journal.titleCanadian Respiratory Journales
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::EOXI de Santiago de Compostela - Complexo Hospitalario Universitario de Santiago de Compostela::Neumoloxíaes
dc.organizationServizo Galego de Saúde::Estrutura de Xestión Integrada (EOXI)::Instituto de Investigación Sanitaria de Santiago de Compostela (IDIS)es
dc.page.initial2950751es
dc.rights.accessRightsopenAccess
dc.subject.decsdrenaje *
dc.subject.decshumanos *
dc.subject.decscatéteres *
dc.subject.keywordCHUSes
dc.subject.keywordIDISes
dc.typefidesArtículo de Revisiónes
dc.typesophosArtículo de Revisiónes
dc.volume.number2020es


Files in this item

This item appears in the following Collection(s)

Show simple item record

Atribución 4.0 Internacional
Except where otherwise noted, this item's license is described as Atribución 4.0 Internacional